O
ATRS

OrbiMed’s Antares Pharma, Inc. ATRS Stock Holding History

OrbiMed’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-3,213,900
Closed -$11.2M – 154
2014
Q1 		$11.2M Sell
3,213,900
-1,378,100
-30% -$6.11M 0.14% 88
2013
Q4 		$20.5M Buy
4,592,000
+227,000
+5% +$925K 0.31% 63
2013
Q3 		$17.7M Sell
4,365,000
-4,834,000
-53% -$21.1M 0.33% 58
2013
Q2 		$38.3M Buy
+9,199,000
New +$35.5M 0.86% 34

Other funds holding ATRS

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Broadfin Capital New York $403M AUM 100.56% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
WHI
William Harris Investors Chicago, Illinois $347M AUM 3.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
KCM
Kingdon Capital Management New York $597M AUM 51.11% 1-Year Est. Return